Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
These costly U.S. attacks failed to achieve their goals, but were conducted in order to inflict a blow against Yemen, for daring to challenge the Israelis.